help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1157
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/12/4896    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fechner, P. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fechner, P. Y.
Related Collections
Right arrow Female Endocrinology
Right arrow Pediatric Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 12 4896-4902
Copyright © 2006 by The Endocrine Society

Differences in Follicle-Stimulating Hormone Secretion between 45,X Monosomy Turner Syndrome and 45,X/46,XX Mosaicism Are Evident at an Early Age

Patricia Y. Fechner, Marsha L. Davenport, Rebecca L. Qualy, Judith L. Ross, Daniel F. Gunther, Erica A. Eugster, Carol Huseman, Anthony J. Zagar, Charmian A. Quigley on behalf of the Toddler Turner Study Group

Division of Pediatric Endocrinology (P.Y.F.), Stanford University, Stanford, California 94305-5208; Division of Pediatric Endocrinology (M.L.D.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599; United States Medical Division (Endocrinology) (R.L.Q., A.J.Z., C.A.Q.), Lilly Research Laboratories, Indianapolis, Indiana 46285; Division of Endocrinology (J.L.R.), Thomas Jefferson University, Philadelphia, Pennsylvania 19107; Children’s Hospital and Regional Medical Center (D.F.G.), University of Washington School of Medicine, Seattle, Washington 98105; Division of Pediatric Endocrinology (E.A.E.), Riley Hospital for Children, Indiana University, Indianapolis, Indiana 46202; and Children’s Mercy Hospital (C.H.), Kansas City, Missouri 64108

Address all correspondence and requests for reprints to: Patricia Y. Fechner, M.D., Division of Pediatric Endocrinology, Children’s Hospital and Medical Regional Center, 4800 Sand Point Way NE, Seattle, Washington 98105. E-mail: Patricia.Fechner{at}seattlechildrens.org.

Context: Little information exists regarding FSH values in very young girls with Turner syndrome (TS).

Objectives: The objective of the study was to evaluate the pattern, natural progression, and karyotype-related differences in FSH secretion in young, prepubertal girls with TS.

Study Design: FSH was measured at study entry and annually for 2 yr.

Setting: The Toddler Turner study was conducted at 11 U.S. pediatric endocrine centers.

Study Participants: Eighty-eight girls with karyotype-proven TS aged 9 months to 4 yr participated in the study.

Main Outcome Measures: By-karyotype differences in FSH concentration and age-related changes in FSH were measured.

Results: Mean (± SD) FSH was markedly elevated in the 45,X (n = 56: 68.3 ± 36.0 IU/liter) and Other groups [n = 15 (excluding three subjects with Y-containing karyotypes): 52.7 ± 50.8 IU/liter] but was minimally elevated in girls with 45,X/46,XX mosaicism (n = 14: 10.1 ± 13.5 IU/liter, P < 0.005 both comparisons). Over the 2-yr period, FSH declined in the 45,X group (–13.4 IU/liter·yr, P < 0.0001). Nonetheless, only three of 159 FSH values fell within normal range for age at any time during the 2-yr study. FSH decline was similar in the Other group (–14.3 IU/liter·yr, P = 0.0032). In contrast, no significant decrease in FSH with age was observed in the 45,X/46,XX group.

Conclusions: In contrast to the original report of FSH concentrations in individuals with TS, this study demonstrates distinct differences in patterns of FSH secretion between young girls with monosomy TS, who have persistent elevation of FSH to age 6 yr, and those with 45,X/46,XX mosaicism, whose FSH values suggest retained ovarian function in the majority. These findings have implications for patient management and family counseling.




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
M. L. DAVENPORT
Moving Toward an Understanding of Hormone Replacement Therapy in Adolescent Girls: Looking through the Lens of Turner Syndrome
Ann. N.Y. Acad. Sci., June 1, 2008; 1135(1): 126 - 137.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. L. Davenport, B. J. Crowe, S. H. Travers, K. Rubin, J. L. Ross, P. Y. Fechner, D. F. Gunther, C. Liu, M. E. Geffner, K. Thrailkill, et al.
Growth Hormone Treatment of Early Growth Failure in Toddlers with Turner Syndrome: A Randomized, Controlled, Multicenter Trial
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3406 - 3416.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society